Montreal and Boston-based Repare Therapeutics, a precision oncology company, has closed US$82.5 million in Series B financing. Cowen Healthcare Investments led the round. Other participants in the financing included OrbiMed, Redmile, BVF Partners LP, Logos Capital, Versant Ventures, MPM Capital, Fonds de solidarité FTQ and BDC Capital. In addition to the funding, Kevin Raidy, managing partner at Cowen Healthcare Investments and Dr. David Bonita, a partner at OrbiMed, will join Repare’s board of directors.
Source: Press Release